REQUEST A DEMO
Total
USD $0.00
Search more companies

Avesta Farmacevtika OOO (Авеста Фармацевтика ООО) (Russia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Avesta Farmacevtika OOO Profile Updated: October 18, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Avesta Farmacevtika OOO (Авеста Фармацевтика ООО) is an enterprise in Russia, with the main office in Moscow. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. Avesta Farmacevtika OOO (Авеста Фармацевтика ООО) was incorporated on June 04, 2004. The total number of employees is currently 18 (2009). There was a net sales revenue increase of 18.48% reported in Avesta Farmacevtika OOO (Авеста Фармацевтика ООО)’s latest financial highlights for 2024. A growth of 8.61% was recorded in its total assets. The net profit margin of Avesta Farmacevtika OOO (Авеста Фармацевтика ООО) increased by 0.1% in 2024.

Headquarters
Varshavskoe, 33
Moscow; Moscow; Postal Code: 117105

Contact Details: Purchase the Avesta Farmacevtika OOO (Авеста Фармацевтика ООО) report to view the information.

Basic Information
Total Employees:
Purchase the Avesta Farmacevtika OOO (Авеста Фармацевтика ООО) report to view the information.
Registered Capital:
Purchase the Avesta Farmacevtika OOO (Авеста Фармацевтика ООО) report to view the information.
Financial Auditors:
Purchase the Avesta Farmacevtika OOO (Авеста Фармацевтика ООО) report to view the information.
Incorporation Date:
June 04, 2004
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Rafarm OOO
90%
Company Performance
Financial values in the chart are available after Avesta Farmacevtika OOO (Авеста Фармацевтика ООО) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
18.48%
Total operating revenue
18.48%
Operating profit (EBIT)
32.4%
Net Profit (Loss) for the Period
48.38%
Total assets
8.61%
Total equity
26.62%
Operating Profit Margin (ROS)
0.23%
Net Profit Margin
0.1%
Return on Equity (ROE)
3.09%
Debt to Equity Ratio
-8.5%
Quick Ratio
0.05%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?